Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd (SHE:301126)
China
· Delayed Price · Currency is CNY 10.74
+0.11 (1.03%)
At close: May 16, 2025, 2:57 PM CST
SHE:301126 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 5,253 | 5,233 | 3,894 | 3,279 | 2,586 | 2,335 | Upgrade
|
| Other Revenue | - | - | 9.37 | 13.5 | 6.12 | 5.15 | Upgrade
|
| Revenue | 5,253 | 5,233 | 3,904 | 3,292 | 2,592 | 2,340 | Upgrade
|
| Revenue Growth (YoY) | 21.95% | 34.07% | 18.56% | 27.01% | 10.79% | -4.75% | Upgrade
|
| Cost of Revenue | 4,234 | 4,193 | 3,335 | 2,901 | 2,292 | 2,073 | Upgrade
|
| Gross Profit | 1,019 | 1,040 | 568.05 | 391.68 | 300.35 | 266.32 | Upgrade
|
| Selling, General & Admin | 823.99 | 825.02 | 421.39 | 254.61 | 148.43 | 132.68 | Upgrade
|
| Research & Development | 17.31 | 16.26 | 7.17 | 0.52 | - | - | Upgrade
|
| Other Operating Expenses | -15.62 | -10.46 | 1.97 | 11.58 | 10.13 | 8.91 | Upgrade
|
| Operating Expenses | 825.68 | 830.81 | 445.44 | 283.46 | 172.06 | 145.76 | Upgrade
|
| Operating Income | 192.87 | 209.39 | 122.61 | 108.23 | 128.3 | 120.56 | Upgrade
|
| Interest Expense | - | - | -69.51 | -40.75 | -34.89 | -31.55 | Upgrade
|
| Interest & Investment Income | - | - | 5.3 | 7.74 | 1.05 | 0.81 | Upgrade
|
| Other Non Operating Income (Expenses) | -120.9 | -121.28 | -9.25 | -4.74 | -2.68 | -2.19 | Upgrade
|
| EBT Excluding Unusual Items | 71.97 | 88.11 | 49.15 | 70.48 | 91.79 | 87.63 | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.38 | -0.38 | -0.15 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 2.02 | 1.38 | 1.11 | 0.32 | - | -0 | Upgrade
|
| Asset Writedown | -13.12 | -13.12 | -0.48 | -0.01 | - | - | Upgrade
|
| Other Unusual Items | - | - | -1.07 | 5.39 | 4.22 | 2.5 | Upgrade
|
| Pretax Income | 60.49 | 76 | 48.55 | 76.17 | 96.01 | 90.13 | Upgrade
|
| Income Tax Expense | 20.59 | 24.66 | 10.54 | 20.85 | 27.75 | 25.27 | Upgrade
|
| Earnings From Continuing Operations | 39.9 | 51.33 | 38.01 | 55.32 | 68.26 | 64.85 | Upgrade
|
| Minority Interest in Earnings | -29.61 | -24.76 | -3.71 | -4.25 | - | - | Upgrade
|
| Net Income | 10.28 | 26.57 | 34.3 | 51.08 | 68.26 | 64.85 | Upgrade
|
| Net Income to Common | 10.28 | 26.57 | 34.3 | 51.08 | 68.26 | 64.85 | Upgrade
|
| Net Income Growth | -73.26% | -22.52% | -32.85% | -25.17% | 5.25% | -26.01% | Upgrade
|
| Shares Outstanding (Basic) | 190 | 204 | 202 | 204 | 155 | 154 | Upgrade
|
| Shares Outstanding (Diluted) | 190 | 204 | 202 | 204 | 155 | 154 | Upgrade
|
| Shares Change (YoY) | -5.68% | 1.32% | -1.25% | 31.70% | 0.47% | 0.41% | Upgrade
|
| EPS (Basic) | 0.05 | 0.13 | 0.17 | 0.25 | 0.44 | 0.42 | Upgrade
|
| EPS (Diluted) | 0.05 | 0.13 | 0.17 | 0.25 | 0.44 | 0.42 | Upgrade
|
| EPS Growth | -71.65% | -23.53% | -32.00% | -43.18% | 4.76% | -26.32% | Upgrade
|
| Free Cash Flow | -151.06 | -163.1 | -199.57 | -702.69 | -195.1 | -197.41 | Upgrade
|
| Free Cash Flow Per Share | -0.80 | -0.80 | -0.99 | -3.44 | -1.26 | -1.28 | Upgrade
|
| Dividend Per Share | - | - | 0.040 | 0.029 | 0.034 | - | Upgrade
|
| Dividend Growth | - | - | 37.93% | -14.71% | - | - | Upgrade
|
| Gross Margin | 19.39% | 19.88% | 14.55% | 11.90% | 11.59% | 11.38% | Upgrade
|
| Operating Margin | 3.67% | 4.00% | 3.14% | 3.29% | 4.95% | 5.15% | Upgrade
|
| Profit Margin | 0.20% | 0.51% | 0.88% | 1.55% | 2.63% | 2.77% | Upgrade
|
| Free Cash Flow Margin | -2.88% | -3.12% | -5.11% | -21.34% | -7.53% | -8.44% | Upgrade
|
| EBITDA | 367.13 | 356.21 | 159.68 | 130.85 | 142.38 | 133.15 | Upgrade
|
| EBITDA Margin | 6.99% | 6.81% | 4.09% | 3.98% | 5.49% | 5.69% | Upgrade
|
| D&A For EBITDA | 174.26 | 146.82 | 37.07 | 22.63 | 14.08 | 12.59 | Upgrade
|
| EBIT | 192.87 | 209.39 | 122.61 | 108.23 | 128.3 | 120.56 | Upgrade
|
| EBIT Margin | 3.67% | 4.00% | 3.14% | 3.29% | 4.95% | 5.15% | Upgrade
|
| Effective Tax Rate | 34.04% | 32.46% | 21.72% | 27.37% | 28.90% | 28.04% | Upgrade
|
| Revenue as Reported | - | - | 3,904 | 3,292 | 2,592 | 2,340 | Upgrade
|
| Advertising Expenses | - | - | 34.34 | 8.87 | - | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.